<DOC>
	<DOCNO>NCT02146469</DOCNO>
	<brief_summary>The objective study follow : 1 . To know antibody level different interval receive 1 dose varicella vaccine . 2 . To know safety effectiveness receive 2 dos varicella vaccine different interval . 3 . To know safety effectiveness receive varicella vaccine MMR time . To achieve , study selects child specific varicella vaccine history , give 1 2 dos varicella vaccine , collect blood specimen make follow-up visit vaccination . All blood specimen test third-party detection institution .</brief_summary>
	<brief_title>Study Effectiveness 2-dose Live Attenuated Varicella Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 1 7 Without previous history varicella With axillary temperature ≤37.5℃ time vaccination Appropriate varicella vaccination history With guardian signing informed consent available clinical observation Hypersensitive active substance vaccine include excipients antibiotic With acute illness , severe acute attack chronic illness fever With immunodeficiency weaken immune system treat immunosuppressant drug Suffering brain disease , uncontrolled epilepsy progressive nerve system disease With family personal history seizure , chronic illness , epilepsy allergy With unknown immunization history unable follow immunization schedule EPI Received vaccine within 4 week willing receive vaccine 1 month With hemorrhagic tendency prolong period bleed Received whole blood , plasma immunoglobulin within 5 month Received systemic antibiotic antiviral treatment acute illness within 7 day With axillary temperature ≥38℃ within 3 day Participating another clinical trial Any situation might influence consequence clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>varicella vaccination</keyword>
</DOC>